Advanced Biomed Inc. (ADVB) vs Precipio, Inc. (PRPO)

Advanced Biomed Inc. and Precipio, Inc. are both Diagnostics & Research companies. Precipio, Inc. is the larger, with a market value of $43.8M against $10.4M — 4.2× the size. Precipio, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 1.3×. Advanced Biomed Inc. has the higher net margin (0.00% vs −4.47%) and the lower return on invested capital (−29.3% vs −7.63%). Across the 13 metrics below, Advanced Biomed Inc. leads on 8 and Precipio, Inc. on 5.

Valuation

Metric ADVB PRPO Diagnostics & Research median
P/E 1.35 n/m 33.95
P/S n/m 1.55 4.87
P/B 0.91 2.86 3.12
Price to free cash flow n/m 53.57 34.02
EV/EBITDA n/m 135.71 25.20
EV/Sales n/m 1.48 5.66
Earnings yield 74.15% (2.71%) (1.75%)
Free cash flow yield (35.24%) 1.87% (0.13%)

Profitability

Metric ADVB PRPO Diagnostics & Research median
Gross margin — 44.11% 50.89%
Operating margin 0.00% (5.68%) (8.57%)
Net margin 0.00% (4.47%) (6.37%)
Free cash flow margin 0.00% 2.90% 0.00%
Return on equity 79.17% (8.98%) (2.92%)
Return on assets 55.78% (6.05%) (6.71%)
Return on invested capital (29.27%) (7.63%) 0.00%

Growth

Metric ADVB PRPO Diagnostics & Research median
Revenue growth (TTM) — 28.04% 7.69%
EPS growth (last fiscal year) (15.01%) 92.15% —
Revenue growth, 5-year CAGR — 31.60% 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB PRPO Diagnostics & Research median
Debt to equity 0.00 0.07 0.11
Current ratio 7.38 1.77 2.02
Net debt to EBITDA 1.08 (3.30) 0.78

Dividend

Metric ADVB PRPO Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio — 0.00 0.00

Size

Metric ADVB PRPO Diagnostics & Research median
Market cap 10.42m 43.81m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack